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（学位論文のタイトル） 
 
DNMT3B7 expression related to MENT expression and its promoter methylation in human 
lymphomas 
 
DNMT3B バリアント DNMT3B7 はヒトリンパ腫において MENT の発現とプロモーターの 
メチル化に関与する 
 
 
 
（学位論文の要旨） 
 
Catalytically inactive DNA methyltransferase (DNMT) 3B7 is the most highly expressed 
splice variant of DNMT3B in cancer cells. It was recently reported that the loss of DNMT3B 
function led to overexpression of the MEthylated in Normal Thymocyes (MENT) 
proto-oncogene and accelerated mouse lymphomagenesis. We investigated the relative mRNA 
expression levels of DNMT3B aberrant splice variant DNMT3B7 and its relationship to 
proto-oncogene MENT overexpression and promoter methylation in human lymphoma. The 
mRNA expression levels of DNMTs, DNMT3B7 and MENT were assessed by quantitative 
real-time PCR. A combined bisulfite restriction analysis (COBRA) was used to evaluate the 
MENT promoter methylation.  The expression levels of DNMT3B7 and MENT were 
significantly (p <0.0001 and p < 0.01) higher in lymphomas than in non-malignant 
tissues/peripheral blood mononuclear cells by 7.3-fold and 2.4-fold, respectively. The 
expression of DNMT3B7 and MENT were associated with MENT promoter hypomethylation. 
Morever, MENT was more highly expressed and hypomethylated in mantle cell lymphoma 
(MCL) than that in diffuse large B cell lymphoma (DLBCL) cases. The overexpression of the 
DNMT3B7 splice variant might interfere with the normal DNA methylation mechanism 
required for silencing the MENT  proto-oncogene, and may accelerate human 
lymphomagenesis. 
